Abhishek Integr. (AILIMITED)

Cyclical

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹94
Market Cap₹56.6 Cr
P/E Ratio20.57
ROCE13.54%
ROE—%
Dividend Yield0%
Profit Growth17.86%
Debt/Equity
Sales Growth21.69%
Promoter Holding60.92%
52-Week Range₹19.8 — ₹94
SectorConstruction

Strengths

Concerns

AI Analysis

At ₹39.55, Abhishek Integr. has a market cap of only ₹22 crore. That is tiny, and I like small companies only when the numbers show obvious financial strength; here the evidence is mixed. Sales grew 21.69% and profit grew 17.86%, so the business is expanding. ROCE of 13.54% is respectable for civil construction, and the Piotroski F-score of 7/9 suggests the company is not deteriorating on operating metrics. Promoter holding at 60.92% gives some comfort. But value investing demands a margin of safety, and I do not see it at 20.57 times earnings. Worse, the latest quarter shows net profit of zero rupees. An earnings figure of ₹0 Cr is a flashing yellow light. For a cyclical construction player, quarterly profits can be lumpy, but a zero at the most recent quarter forces me to question the quality of trailing earnings. The PEG of 1.04 makes the growth price look reasonable only if the 17.86% profit growth continues, and in this industry that is not a safe assumption. There is no dividend to compensate while waiting. I also have no book value or debt-to-equity data; without that, I cannot judge the balance sheet's robustness. Graham would ask: Is this a business I can understand with durable economics? Civil construction is competitive and low-moat, and micro-cap liquidity adds risk. The 52-week range of ₹23.75 to ₹53.00 shows how violently this stock can swing. I would need the next few quarters to prove real profits, and I would want debt and book value disclosed. Given the cyclical end-market and zero recent profit, I cannot treat this as a dependable compounder. It is a possible cyclical watch item, not a buy at this price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer